ES2530623T3 - Utilización de un ácido indazolmetoxialcanoico para preparar una composición farmacéutica - Google Patents

Utilización de un ácido indazolmetoxialcanoico para preparar una composición farmacéutica Download PDF

Info

Publication number
ES2530623T3
ES2530623T3 ES11185914T ES11185914T ES2530623T3 ES 2530623 T3 ES2530623 T3 ES 2530623T3 ES 11185914 T ES11185914 T ES 11185914T ES 11185914 T ES11185914 T ES 11185914T ES 2530623 T3 ES2530623 T3 ES 2530623T3
Authority
ES
Spain
Prior art keywords
base
tiles
vertical blade
indazolmethoxyalkanoic
prepare
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11185914T
Other languages
English (en)
Spanish (es)
Inventor
Angelo Guglielmotti
Giuseppe Biondi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Application granted granted Critical
Publication of ES2530623T3 publication Critical patent/ES2530623T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mixers Of The Rotary Stirring Type (AREA)
ES11185914T 2006-11-24 2007-11-13 Utilización de un ácido indazolmetoxialcanoico para preparar una composición farmacéutica Active ES2530623T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002254A ITMI20062254A1 (it) 2006-11-24 2006-11-24 Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca

Publications (1)

Publication Number Publication Date
ES2530623T3 true ES2530623T3 (es) 2015-03-04

Family

ID=38198404

Family Applications (2)

Application Number Title Priority Date Filing Date
ES11185914T Active ES2530623T3 (es) 2006-11-24 2007-11-13 Utilización de un ácido indazolmetoxialcanoico para preparar una composición farmacéutica
ES07819835T Active ES2403584T3 (es) 2006-11-24 2007-11-13 Utilización de un ácido indazolmetoxialcanoico para reducir los niveles de triglicéridos, colesterol y glucosa

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES07819835T Active ES2403584T3 (es) 2006-11-24 2007-11-13 Utilización de un ácido indazolmetoxialcanoico para reducir los niveles de triglicéridos, colesterol y glucosa

Country Status (23)

Country Link
US (2) US8198310B2 (cg-RX-API-DMAC7.html)
EP (2) EP2097080B1 (cg-RX-API-DMAC7.html)
JP (1) JP5192490B2 (cg-RX-API-DMAC7.html)
KR (1) KR101413616B1 (cg-RX-API-DMAC7.html)
CN (1) CN101541323B (cg-RX-API-DMAC7.html)
AR (1) AR063894A1 (cg-RX-API-DMAC7.html)
AU (1) AU2007323351B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0718522A2 (cg-RX-API-DMAC7.html)
CA (1) CA2666371C (cg-RX-API-DMAC7.html)
CY (1) CY1116664T1 (cg-RX-API-DMAC7.html)
DK (2) DK2409698T3 (cg-RX-API-DMAC7.html)
EA (1) EA016885B1 (cg-RX-API-DMAC7.html)
ES (2) ES2530623T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20125570B (cg-RX-API-DMAC7.html)
IL (1) IL198286A (cg-RX-API-DMAC7.html)
IT (1) ITMI20062254A1 (cg-RX-API-DMAC7.html)
MX (1) MX2009004295A (cg-RX-API-DMAC7.html)
PL (2) PL2097080T3 (cg-RX-API-DMAC7.html)
PT (2) PT2409698E (cg-RX-API-DMAC7.html)
SG (1) SG176508A1 (cg-RX-API-DMAC7.html)
SI (2) SI2409698T1 (cg-RX-API-DMAC7.html)
UA (1) UA97123C2 (cg-RX-API-DMAC7.html)
WO (1) WO2008061671A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
US8350052B2 (en) 2009-08-03 2013-01-08 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Process for the preparation of 1-benzyl-3-hydroxymethyl-1H-indazole and its derivatives and required magnesium intermediates
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
ES2789849T3 (es) * 2014-05-15 2020-10-26 Translatum Medicus Inc Composiciones y procedimientos para el tratamiento y diagnóstico de trastornos oculares
EP3990433A4 (en) 2019-06-25 2023-07-26 Translatum Medicus Inc. METHODS FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES
BR112022026550A2 (pt) 2020-06-27 2023-01-17 Crescenta Biosciences Composição de compostos que modulam o metabolismo celular e métodos de uso
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1131779B (it) * 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1230441B (it) * 1989-02-07 1991-10-23 Acraf Eteri della serie dell'indazolo
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1276031B1 (it) * 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
US6077539A (en) * 1996-11-12 2000-06-20 Pozen, Inc. Treatment of migraine headache
IT1293794B1 (it) 1997-07-28 1999-03-10 Acraf Farmaco attivo nel ridurre la produzione di proteina mcp-1
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
JP2002501889A (ja) * 1998-02-02 2002-01-22 トラスティーズ オブ タフツ カレッジ グルコース代謝を調節する方法、およびそれに関連する試薬
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
US6197786B1 (en) * 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
ITFI20010230A1 (it) * 2001-11-29 2003-05-29 Menarini Int Operations Lu Sa Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
US20060030582A1 (en) * 2002-04-29 2006-02-09 Demartino Julie Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
EP1877410A1 (en) * 2005-04-29 2008-01-16 Nycomed GmbH Mutual prodrug compounds for use as antiinflammatory agents with gastrointestinal protective activity
WO2007062469A1 (en) * 2005-12-01 2007-06-07 Flinders Technologies Pty Ltd Methods and compositions for preventing and/or treating pancreatitis
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca

Also Published As

Publication number Publication date
BRPI0718522A2 (pt) 2013-11-12
EA200970506A1 (ru) 2009-10-30
CA2666371C (en) 2014-05-06
CA2666371A1 (en) 2008-05-29
SG176508A1 (en) 2011-12-29
ITMI20062254A1 (it) 2008-05-25
IL198286A0 (en) 2010-02-17
AU2007323351B2 (en) 2013-05-02
WO2008061671A2 (en) 2008-05-29
CN101541323B (zh) 2012-01-04
EP2409698B1 (en) 2015-01-21
HK1129071A1 (en) 2009-11-20
PT2409698E (pt) 2015-02-10
AR063894A1 (es) 2009-02-25
SI2409698T1 (sl) 2015-04-30
EP2409698A1 (en) 2012-01-25
HK1165275A1 (en) 2012-10-05
US8198310B2 (en) 2012-06-12
PL2409698T3 (pl) 2015-06-30
US8846745B2 (en) 2014-09-30
EA016885B1 (ru) 2012-08-30
JP5192490B2 (ja) 2013-05-08
KR101413616B1 (ko) 2014-07-01
EP2097080A2 (en) 2009-09-09
ES2403584T3 (es) 2013-05-20
GEP20125570B (en) 2012-07-10
IL198286A (en) 2016-03-31
US20100069456A1 (en) 2010-03-18
DK2097080T3 (da) 2013-05-21
SI2097080T1 (sl) 2013-05-31
WO2008061671A3 (en) 2008-11-27
US20120283307A1 (en) 2012-11-08
EP2097080B1 (en) 2013-02-20
AU2007323351A1 (en) 2008-05-29
KR20090081410A (ko) 2009-07-28
PL2097080T3 (pl) 2013-07-31
JP2010510263A (ja) 2010-04-02
CN101541323A (zh) 2009-09-23
UA97123C2 (uk) 2012-01-10
MX2009004295A (es) 2009-05-05
CY1116664T1 (el) 2017-03-15
DK2409698T3 (en) 2015-04-27
PT2097080E (pt) 2013-04-01

Similar Documents

Publication Publication Date Title
ES2530622T3 (es) Dispositivo para la correcta colocación de baldosas
ES2530623T3 (es) Utilización de un ácido indazolmetoxialcanoico para preparar una composición farmacéutica
USD673280S1 (en) Orthopedic device
USD603943S1 (en) Plumbing fixture
USD609602S1 (en) Coupler fitting for an artificial tree segment
PE20120596A1 (es) Recipiente de llenado en caliente
USRE45460E1 (en) Water closet
USD712536S1 (en) Biological fluid container
HK1224503A2 (zh) 一种弹簧分离送料装置及方法
USD615635S1 (en) Plumbing fixture
GB2459397A (en) Water closet bolt
USD621239S1 (en) Upper beam slab bolster
CA2690946A1 (en) Nipple for feeding liquids to calves and other mammals
DE602005011326D1 (de) Feste pharmazeutische zusammensetzung mit donepezilhydrochlorid
ITTO20060525A1 (it) Dispositivo bipolare integrato di tipo verticale e relativo procedimento per la sua fabbricazione
USD594098S1 (en) Water closet
CN201303541Y (zh) 一种猪用采食器
CN202504909U (zh) 一种筷子筒
CN201379263Y (zh) 氧气表、湿化瓶存放支架
FR2918071B1 (fr) Procede d'incorporation d'alcool dans les carburants
CN202069350U (zh) 一种防倾倒杯托
CN202458109U (zh) 简便型盒里用皂盒
USD638093S1 (en) Fishing rod tip orifice
CN202629575U (zh) 一种气瓶底座
CN202312504U (zh) 一种新型组合式碗